Professor identifies a new protein that is associated with tumors
A newly discovered "Ras" protein, which is related to a group of proteins known to be a factor in nearly 30% of all human tumors, has been identified by a Yale professor.
"There are three known Ras proteins," says Sankar Ghosh, associate professor in the Departments of Immunobiology, Molecular Biophysics and Biochemistry, and of Molecular, Cellular & Developmental Biology. "They are associated with about 30% of all human tumors and therefore are one of the most intensely studied proteins in biology. What we found is basically a new subclass of Ras proteins."
The Ras proteins have been found to be mutated in 50% of colon tumors and 90% of a class of pancreatic tumors.
What is most noteworthy about this particular Ras protein is that, in its natural form, it resembles the other Ras proteins in their mutated form, says Ghosh, who also is an associate investigator for the Howard Hughes Medical Institute. His findings were published in the February issue of the journal Science.
Ghosh and his collaborator, Jae Woon Lee of Chonnam National University in Korea, believe this new class of Ras protein helps regulate the activity of a transcription factor known as NFkB. Transcription is the process by which messenger RNA is synthesized from a DNA template, resulting in the transfer of genetic information from the DNA molecule to messenger RNA.
Among the questions the investigators plan to pursue in the future is whether this new protein is also associated with cancer. In order for Ras proteins to cause cancer they have to localize in the membrane, but this protein does not have the sequences that allow it to go to the membrane, Ghosh says.
"However, it is possible that in certain cancers this protein could be mutated so that it could be localized to the membrane," he says.
-- By Jacqueline Weaver
T H I SW E E K ' SS T O R I E S
Gift honors Zigler for work shaping nation's policies on children's issues
Bulletin Home|Visiting on Campus|
Calendar of Events|Bulletin Board
|